8AP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Agios Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 29.4 EUR 0.68% Market Closed

Market Cap: €1.7B

A	Agios Pharmaceuticals Inc F:8AP	US
O	Onity Group Inc F:OW0A	US
	Telefonica SA MAD:TEF	ES
S	Shimao Group Holdings Ltd F:QHI	HK
	Kalray SA F:3FS	FR
	Gold Fields Ltd F:EDGA	ZA
T	Tvardi Therapeutics Inc F:69C	US
	Star Micronics Co Ltd F:2ZN	JP
I	IMC SA F:IM4	UA
	Metrospaces Inc OTC:MSPC	US
B	Bossard Holding AG F:0B7	CH
	Rand Mining Ltd F:014	AU

Profitability Summary

Agios Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

92%

Strong 3Y Average Gross Margin

89%

Gross Margin is Increasing

89% > 92%

Negative Operating Margin

-467%

Negative 3Y Average Operating Margin

-661%

Operating Margin is Increasing

-1.600% > -467%

Negative Net Margin

-418%

Negative 3Y Average Net Margin

-2%

Net Margin is Increasing

-914% > -418%

Negative Free Cash Flow Margin

-371%

Negative 3Y Average Free Cash Flow Margin

-922%

Free Cash Flow Margin is Increasing

-1.210% > -371%

Negative ROE

-34%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-56%

ROIC is Increasing

-97% > -93%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.